Seminars in Oncology

1

CME test answer sheet and participant information form

Journal:

Year:

2003

Language:

english

File:

PDF, 17 KB

english, 2003

2

CME test

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 45 KB

english, 2003

3

CME test answer sheet

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 29 KB

english, 2003

4

Evaluation form

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 33 KB

english, 2003

5

Faculty disclosure

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 31 KB

english, 2003

6

Unlabeled uses of commercial products or investigational uses not yet approved

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 37 KB

english, 2003

7

Introduction

Richard M. Goldberg

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 53 KB

english, 2003

8

Oxaliplatin-safety profile: neurotoxicity

Axel Grothey

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 139 KB

english, 2003

9

Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the national cancer institute organ dysfunction working group

James H Doroshow, Timothy W Synold, David Gandara, Sridhar Mani, Scot C Remick, Daniel Mulkerin, Anne Hamilton, Sunil Sharma, Ramesh K Ramanathan, Heinz Josef Lenz, Martin Graham, Jeffrey Longmate, Ch

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 114 KB

english, 2003

10

Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working group

Chris H Takimoto, Scot C Remick, Sunil Sharma, Sridhar Mani, Ramesh K Ramanathan, James H Doroshow, Anne Hamilton, Daniel Mulkerin, Martin Graham, Graham F Lockwood, Percy Ivy, Merrill Egorin, Denis G

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 112 KB

english, 2003

11

Oxaliplatin-based combined-modality therapy for rectal cancer

Bruce D Minsky

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 96 KB

english, 2003

12

Colorectal metastases confined to the liver: a unique opportunity?

Alan P Venook

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 77 KB

english, 2003

13

Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer

J.Philip Kuebler, Aimery de Gramont

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 153 KB

english, 2003

14

Pharmacogenomics in colorectal cancer

Heinz Josef Lenz

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 89 KB

english, 2003

15

The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas

Paulo M Hoff, Charles S Fuchs

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 112 KB

english, 2003

16

Opportunities for newer agents in combination with oxaliplatin

Howard S Hochster

Journal:

Seminars in Oncology

Year:

2003

Language:

english

File:

PDF, 83 KB

english, 2003

17

Volume 30; Issue supp-S15

CME test answer sheet and participant information form

CME test

CME test answer sheet

Evaluation form

Faculty disclosure

Unlabeled uses of commercial products or investigational uses not yet approved

Introduction

Oxaliplatin-safety profile: neurotoxicity

Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the national cancer institute organ dysfunction working group

Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working group

Oxaliplatin-based combined-modality therapy for rectal cancer

Colorectal metastases confined to the liver: a unique opportunity?

Recent experience with oxaliplatin or irinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer

Pharmacogenomics in colorectal cancer

The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas

Opportunities for newer agents in combination with oxaliplatin

TOC